Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Odelayon Dec 12, 2018 7:17am
55 Views
Post# 29101661

RE:Hmmm

RE:HmmmEAST.v is well established and insanely undervalued.

Another guy posted this recap:

Recap of EastWest Biosciences

 

June 2017
EastWest
 currently has 35,079,779 common shares issued and outstanding, of which the sole shareholder holding more than 10% of the shares is Rodney Gelineau, Chief Executive Officer of the Company, which holds 16,829,750 common shares ( 47.98%).
 
November 2017
The Company has also seen significant development of its nutraceutical product manufacturing division Orchard Valley Naturals ("OVN"). OVN is a new Health Canada operating facility operating in Pentiction, BC. The same OVN facility has been established by Planet Organic only a few years ago and has the capacity to manufacture significant varieties and volumes of nutraceutical products.
(By 2009, Planet Organic's had $ 127.7 Million from its 76 retail stores and operations across Canada and the USA.
 
Amazon
A distribution agreement between EastWest and Amazon, North America's largest online distributor of natural health products. The Company is now set up on Amazon's sales platform and expects its shipments Natural Advancement hemp-based nutraceutical products to Amazon in November.
 
Over 7000 stores
A distribution agreement with Purity Life Health Products LP ("Purity Life") that distributes high-quality natural healthy living products to a vast network of over 7,000 stores nationwide. Purity Life, Canada's largest natural health product distributor, has selected pet treats, Slim'Dog and Calm'Cat, both of which contain ground-breaking and cricket-based formulas for pets, Purity Life banner, now available in warehouses for shipping.

July 2018

Insider / Pro Group Participation:

   
 

Insider=Y /

 

Name

ProGroup=P

# of Shares

Rodney Gelineau

Y

18,383,333

John MacPhail

Y

2,100,000

Richard Shatto

Y

500,000


Capitalization:

Unlimited shares with no par value of which

 

75,118,207 shares are issued and outstanding

Escrow:

30,170,000 shares


An aggregate of 19,840,000 Common Shares will be subject to 36-month escrow restrictions, with five percent (5%) being releasable upon receipt of final Exchange approval; a further five percent (5%) releasable in six (6) months; a further ten percent (10%) releasable on each of twelve (12) and eighteen (18) months; a further fifteen percent (15%) releasable on each of twenty-four (24) and thirty (30) months and the final forty percent (40%) releasable on thirty-six (36) months. An aggregate of 10,330,000 Common Shares (including the original 2,080,000 Common Shares under the CPC Escrow Agreement) will be subject to 36-month escrow restrictions, with ten percent (10%) of such escrowed shares being releasable upon receipt of final Exchange approval and a further fifteen percent (15%) being releasable on each of the six-month, twelve-month, eighteen-month, twenty-four month, thirty month and thirty-six month anniversaries of such approval.
 
August 2018
The engagement of two Ontario based business consulting firms for the provision of services related to sourcing business development opportunities, strategic, marketing, financial and business plans, access to capital and related matters.
 
 
August 2018
the Company's launch of its innovative hemp food brand Earth's Menu, with the brand's first product Hemp Harmony Hemp Seeds. The launch is a significant milestone in the world of food and beverage in the United States, providing the company with a leading status in the rapidly-growing natural foods market and hemp industry.
 
September 2018
Eastwest Bioscience Expanding Three Brandlines through Retail Network of 2,000 Nationwide Retail Stores.
 
Hagens
EastWest Biosciences Hemp Pet Brand Processes Second Major Purchase Order with Global Manufacturer to Fulfill Product Demand

non-brokered pp, 1 day closed
Announcement of a $ 730,925.25 in units ("Units") announced October 3, 2018, subject to TSXV approval.
 
Eastwest Vision
This commitment of Phytosciences as a consultant to EastWest will be supported by EastWest's ambitious strategy to expand its operations beyond the reach of medical products and medical marijuana and CBD markets. This will allow the Company to conduct trade of fresh and dried marijuana, cannabis oils, and concentrates, formulate research and development of cannabis products, and orchestrate analytical testing.

https://grizzle.com/the-untapped-potential-of-cannabidiol-cbd/
 
This mid-term vision includes acquisition and control of both its supply chain and its distribution chain and what the Company believes will be its real competitive market advantage. To that effect, the Company will also be announcing major acquisitions that will be literally bake-in its own sales distribution, a major market strategy unique to EastWest.

Sangster's
Sangster's is one of Canada's most storied national natural health product franchises. Its acquisition gives EastWest a strategic advantage in becoming the leading hemp focused consumer goods company in Canada and around the globe.
"It's the first of several major steps we are planning to execute our strategic plan to build a vertically integrated global hemp Company.''

We had Sangster's for a song because of Rodney's relationship. East manages 3 of Sangster's 28 branches and possibly 4 soon. They should generate between 6 million and 8.5 million in the next year.

Rodney does not take a salary, of course he should sell shares sometimes but it's pretty good for East's finances.

Between 2.5 and 3.5 million revenues for 2018

Rodney: 'We expect to be north of 10 to 20 millions in a year from 
NOW.

East to annonce a expansion into Europe


https://www.youtube.com/watch?v=wmeWgsQ-00E

https://www.eastwestbioscience.com/
https://naturaladvancement.com/
https://earthsmenu.com/
https://naturalpetscience.com/
https://www.orchardvalenaturals.com/

Bullboard Posts